Tumor-related Lipid Exudation and Associated Tumor-related Complications after Plaque Radiotherapy of Posterior Uveal Melanoma

Brown G.C. , Shields J.A. , Sanborn G. , Augsburger J.J. , Savino P.J. , Schatz N.J. Radiation retinopathy. Ophthalmology 1982; 89: 1494–501.

Brown G.C. , Shields J.A. , Sanborn G. , Augsburger J.J. , Savino P.J. , Schatz N.J. Radiation optic neuropathy. Ophthalmology 1982; 89: 1489–93.

Kim M.K. , Char D.H. , Castro J.L. , Saunders W.M. , Chen G.T. , Stone R.D. Neovascular glaucoma after helium ion irradiation for uveal melanoma. Ophthalmology 1986; 93: 189–93.

Guyer D.R. , Mukai S. , Egan K.M. , Seddon J.M. , Walsh S.M. , Gragoudas E.S. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 1992; 99: 1278–85.

Meecham W.J. , Char D.H. , Kroll S. , Castro J.R. , Blakely E.A. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch Ophthalmol 1994; 112: 197–203.

Summanen P. , Immonen I. , Kivelä T. , Tommila P. , Heikkonen J. , Tarkkanen A. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996; 80: 732–9.

Gündüz K. , Shields C.L. , Shields J.A. , Cater J. , Freire J.E. , Brady L.W. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999; 127: 579–89.

Gündüz K. , Shields C.L. , Shields J.A. , Cater J. , Freire J.E. , Brady L.W. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999; 117: 609–14.

Lumbroso L. , Desjardins L. , Levy C. Intraocular inflammation after proton beam irradiation for uveal melanoma. Br J Ophthalmol 2001; 85: 1305–8.

Detorakis E.T. , Engstrom R.E. Jr. , Wallace R. , Straatsma B.R. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology 2005; 112: 505–10.

Mills M.D. , Harbour J.W. Lipid exudation following plaque radiotherapy for posterior uveal melanoma. Am J Ophthalmol 2006; 141: 594–5.

Boyd S.R. , Gittos A. , Richter M. , Hungerford J.L. , Errington R.D. , Cree I.A. Proton beam therapy and iris neovascularisation in uveal melanoma. Eye 2006; 20: 832–6.

Radin P.P. , Lumbroso-Le Rouic L. , Levy-Gabriel C. , Dendale R. , Sastre X. , Desjardins L. Scleral necrosis after radiation therapy for uveal melanomas: report of 23 cases. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1731–6.

Boldt H.C. , Melia B.M. , Liu J.C. , Reynolds SM ; Collaborative Ocular Melanoma Study Group. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30. Ophthalmology 2009; 116: 106–15.

Mashayekhi A. , Tuncer S. , Shields C.L. , Shields J.A. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture. Ophthalmology 2010; 117: 1013–23.

Char D.H. , Castro J.R. , Quivey J.M. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. Ophthalmology. 1989; 96: 1708–15.

Puusaari I. , Heikkonen J. , Kivelä T. Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004; 111: 1768–77.

Beitler J.J. , McCormick B. , Ellsworth R.M. , Abramson D.H. , Anderson L.L. , Loffredo C. Ocular melanoma: total dose and dose rate effects with Co-60 plaque therapy. Radiology 1990; 176: 275–8.

Lumbroso-Le Rouic L. , Charif Chefchaouni M. , Levy C. 125I plaque brachytherapy for anterior uveal melanomas. Eye 2004; 18: 911–6.

Kleineidam M. , Augsburger J.J. , Hernandez C. , Glennon P. , Brady L.W. Cataractogenesis after Cobalt-60 eye plaque radiotherapy. Int J Radiat Oncol Biol Phys 1993; 26: 625–30.

Kim R.Y. , Hu L.K. , Foster B.S. , Gragoudas E.S. , Young L.H. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996; 103: 2029–36.

Desjardins L. , Lumbroso-Le Rouic L. , Levy-Gabriel C. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res 2006; 38: 255–60.

Kindy-Degnan N.A. , Char D.H. , Castro J.R. Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Am J Ophthalmol 1989; 107: 114–20.

Keunen J.E. , Hooymans J.M. , Ulbig M.W. , Shields C.L. Retinal neovascularization in choroidal melanoma without retinal ischemia. Retina 2002; 22: 371–4.

Vine A.K. Choroidal melanoma with disc and retinal neovascularization. Retina 1983; 3: 118–20.

Lee J. , Logani S. , Lakosha H. , Schroeder R.P. , Simpson R. , Jampol L.M. Preretinal neovascularisation associated with choroidal melanoma. Br J Ophthalmol 2001; 85: 1309–12.

Castella A.P. , Bercher L. , Zografos L. , Egger E. , Herbort C.P. Study of the blood-aqueous barrier in choroidal melanoma. Br J Ophthalmol 1995; 79: 354–7.

Shields C.L. , Shields J.A. , Shields M.B. , Augsburger J.J. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology 1987; 94: 839–46.

Damato B. Vasculopathy after treatment of choroidal melanoma. In: Joussen A.M. , Gardner T.W. , Kirchhof B. , Ryan S.J. , eds. Retinal Vascular Disease, 2nd ed. New York: Springer; 2007; 582–91.

Seddon J.M. , Gragoudas E.S. , Albert D.M. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes. Arch Ophthalmol 1983; 101: 1402–8.

Crawford J.B. , Char D.H. Histopathology of uveal melanomas treated with charged particle radiation. Ophthalmology 1987; 94: 639–43.

Saornil M.A. , Egan K.M. , Gragoudas E.S. , Seddon J.M. , Walsh S.M. , Albert D.M. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992; 110: 1112–8.

Saornil M.A. , Fisher M.R. , Campbell R.J. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 1997; 115: 1395–400.

Mueller A.J. , Bartsch D.U. , Schaller U. , Freeman W.R. , Kampik A. Imaging the microcirculation of untreated and treated human choroidal melanomas. Int Ophthalmol 2001; 23: 385–93.

Avery R.B. , Diener-West M. , Reynolds S.M. , Grossniklaus H.E. , Green W.R. , Albert D.M. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol 2008; 126: 207–12.

Shields C.L. , Cater J. , Shields J.A. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 2002; 120: 933–40.

Missotten G.S. , Notting I.C. , Schlingemann R.O. Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol 2006; 124: 1428–34.

Dunavoelgyi R. , Zehetmayer M. , Simader C. , Schmidt-Erfurth U. Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection. Clin Experiment Ophthalmol 2007; 35: 878–80.

Yeung S.N. , Paton K.E. , Waite C. , Maberley D.A. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma. Can J Ophthalmol 2010; 45: 269–73.

Irvine A.R. , Wood I.S. Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis. Am J Ophthalmol 1987; 103: 790–7.

Archer D.B. , Amoaku W.M. , Gardiner T.A. Radiation retinopathy: clinical, histopathological, ultrastructural and experimental correlations. Eye 1991; 5: 239–51.

Archer D.B. Doyne Lecture. Responses of retinal and choroidal vessels to ionising radiation. Eye 1993; 7: 1–13.

Gragoudas E.S. , Li W. , Lane A.M. , Munzenrider J. , Egan K.M. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 1999; 106: 1571–7, discussion 1577–8.

Viebahn M. , Barracks M.E. Potentiating effect of diabetes in radiation retinopathy. Int J Radiat Oncol Biol Phys 1993; 25: 379–80.

Parsons J.T. , Bova F.J. , Fitzgerald C.R. , Mendenhall W.M. , Million R.R. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 765–73.

De Potter P. , Shields C.L. , Shields J.A. , Cater J.R. , Brady L.W. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol 1996; 114: 1357–65.

Bianciotto C. , Shields C.L. , Pirondini C. , Mashayekhi A. , Furuta M. , Shields J.A. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 2010; 117: 1005–12.

Stack R. , Elder M. , Abdelaal A. , Hidajat R. , Clemett R. New Zealand experience of I125 brachytherapy for choroidal melanoma. Clin Experiment Ophthalmol 2005; 33: 490–4.

Finger P.T. , Chin K.J. , Yu G.P. ; Palladium-103 for Choroidal Melanoma Study Group. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Ophthalmol 2010; 149: 608–15.

Puusaari I. , Heikkonen J. , Kivelä T. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Invest Ophthalmol Vis Sci 2004; 45: 3425–34.

Jensen A.W. , Petersen I.A. , Kline R.W. , Stafford S.L. , Schomberg P.J. , Robertson D.M. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 2005; 63: 101–8.

Rouberol F. , Roy P. , Kodjikian L. , Gérard J.P. , Jean-Louis B. , Grange J.D. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 2004; 137: 893–900.

Harris J.R. , Levene M.B. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 1976; 120: 167–71.

Chan R.C. , Shukovsky L.J. Effects of irradiation on the eye. Radiology 1976; 120: 673–5.

Astrahan M.A. , Luxton G. , Pu Q. , Petrovich Z. Conformal episcleral plaque therapy. Int J Radiat Oncol Biol Phys 1997; 39: 505–19.

Finger P.T. , Lu D. , Buffa A. , DeBlasio D.S. , Bosworth J.L. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys. 1993; 27: 849–54.

Oliver S.C. , Leu M.Y. , DeMarco J.J. , Chow P.E. , Lee S.P. , McCannel T.A. Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma. Arch Ophthalmol 2010; 128: 888–93.

Gragoudas E.S. , Lane A.M. , Regan S. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 2000; 118: 773–8.

Monroe A.T. , Bhandare N. , Morris C.G. , Mendenhall W.M. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005; 61: 856–64.

Mao X.W. , Crapo J.D. , Mekonnen T. Radioprotective effect of a metalloporphyrin compound in rat eye model. Curr Eye Res 2009; 34: 62–72.

Damato B. , Kacperek A. , Chopra M. , Campbell I.R. , Errington R.D. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005; 62: 1405–11.

Bechrakis N.E. , Foerster M.H. Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin 2006; 46: 95–107.

Schilling H. , Bornfeld N. , Talies S. Endoresection of large uveal melanomas after pretreatment by single-dose stereo-tactic convergence irradiation with the Leksell gamma knife: first experience on 46 cases [in German]. Klin Monatsbl Augenheilkd 2006; 223: 513–20.

Damato B. , Foulds W.S. Surgical resection of choroidal melanoma. In: Ryan S.J. , Schachat A.P. , eds. Retina, 4th ed. Philadelphia: Elsevier; 2006: 769–78.

Vásquez L.M. , Somani S. , Altomare F. , Simpson E.R. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma. Can J Ophthalmol 2009; 44: 106–7.